Personalis Change in Accounts Receivable 2018-2024 | PSNL
Personalis change in accounts receivable from 2018 to 2024. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
Personalis Annual Change in Accounts Receivable
(Millions of US $) |
| 2024 |
$10 |
| 2023 |
$-1 |
| 2022 |
$2 |
| 2021 |
$-12 |
| 2020 |
$-3 |
| 2019 |
$1 |
| 2018 |
$-3 |
| 2017 |
$-1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.323B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
